In vitro activities of oral β-lactams at concentrations achieved in humans against penicillin-susceptible and -resistant pneumococci and potential to select resistance

Antimicrobial Agents and Chemotherapy

Volumn 42, Issue 8, 1998, Pages 1973-1979

  Thorburn, Christine E ^a   Knott, Sarah J ^a   Edwards, David I ^b  

^a GLAXOSMITHKLINE   (United Kingdom)

^b UNIVERSITY OF EAST LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; BETA LACTAM ANTIBIOTIC; CEFACLOR; CEFIXIME; CEFPODOXIME; CEFPROZIL; CEFUROXIME; LORACARBEF; PENICILLIN G;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERICIDAL ACTIVITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CROSS RESISTANCE; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG POTENCY; HUMAN; HUMAN TISSUE; MIDDLE EAR EFFUSION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE;

EID: 0031928114     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.42.8.1973     Document Type: Article

References (36)

1. Baquero, F., J. Martínez Beltrán, and E. Loza. 1991. A review of antibiotic resistance patterns of Streptococcus pneumoniae in Europe. J. Antimicrob. Chemother. 28(Suppl. C):31-38.
2. Baquero, F., and M. C. Negri. 1997. Strategies to minimize the development of resistance. J. Chemother. 9(Suppl. 3):29-37.
3. Barry, B., P. Gehanno, and N. Blume. 1994. Clinical outcome of otitis media caused by pneumococci with decreased susceptibility to penicillin. Scand. J. Infect. Dis. 26:446-452.
4. Beque, P., E. N. Garabedian, F. Denoyel, and B. Broussin. 1991. Diffusion du cefixime dans le liquide auriculare chez l'enfant, abstr. 102/C7. In Program and abstracts of the 11th Interdisciplinary Meeting of Anti-Infectious Chemotherapy.
5. Cars, O. 1997. Efficacy of beta-lactam antibiotics: integration of pharmacokinetics and pharmacodynamics. Diagn. Microbiol. Infect. Dis. 27:29-33.
6. Coffey, T. J., M. Daniels, L. K. McDougal, C. G. Dowson, F. C. Tenover, and B. G. Spratt. 1995. Genetic analysis of clinical isolates of Streptococcus pneumoniae with high-level resistance to expanded-spectrum cephalosporins. Antimicrob. Agents Chemother. 39:1306-1313.
7. Cohen, R., F. De La Rocque, M. Boucherat, C. Doit, E. Bingen, and P. Geslin. 1994. Treatment failure in otitis media: an analysis. J. Chemother. 6(Suppl. 4):17-24.
8. Craig, W. A. 1996. Antimicrobial resistance issues of the future. Diagn. Microbiol. Infect. Dis. 25:213-217.
9. Craig, W. A., and D. Andes. 1996. Pharmacokinetics and pharmacodynamics of antibiotics in otitis media. Pediatr. Infect. Dis. J. 15:255-259.
10. Dagan, R., O. Abramson, and E. Leibovitz. 1996. Impaired bacteriologic response to oral cephalosporins in acute otitis media caused by pneumococci with intermediate resistance to penicillin. Pediatr. Infect. Dis. J. 15:980-985.
11. Dowson, C. G., T. J. Coffey, C. Kell, and R. A. Whiley. 1993. Evolution of penicillin resistance in Streptococcus pneumoniae: the role of Streptococcus mitis in the formation of a low affinity PBP 2B in S. pneumoniae. Mol. Microbiol. 9:635-643.
12. Drusano, G. L., and W. A. Craig. 1997. Relevance of pharmacokinetics and pharmacodynamics in the selection of antibiotics for respiratory tract infections. J. Chemother. 9(Suppl. 3):38-44.
13. Fenoll, A., C. Marton Bourgon, R. Munoz, D. Vicioso, and J. Casal. 1991. Serotype, distribution and antimicrobial resistance of Streptococcus pneumoniae isolates causing systemic infections in Spain. Rev. Infect. Dis. 13:56-60.
14. Geslin, P., A. Fremaux, and G. Sissia. 1991. Streptococcus pneumoniae: état actuel de la sensibilité aux beta-lactamamines en France. Med. Mal. Infect. 21:3-11.
15. Geslin, P., A. Fremaux, G. Sissia, C. Spicq, and S. Aberrane. 1994. Epidemiologie de la resistance aux antibiotiques de Streptococcus pneumoniae en France. Med. Mal. Infect. 24:948-961.
16. Grasso, S., G. Meinardi, I. DeCarneri, and V. Tamassia. 1978. New in vitro model to study the effect of antibiotic concentration and rate of elimination on antibacterial activity. Antimicrob. Agents Chemother. 13:570-576.
17. Haddad, J., G. Isaacson, and D. Respler. 1991. Concentration of cefuroxime in serum and middle ear effusion after single dose treatment with cefuroxime axetil. Pediatr. Infect. Dis. J. 10:294-298.
18. Harding, S. M., P. E. O. Williams, and J. Ayrton. 1984. Pharmacology of cefuroxime as the 1-acetoxyethyl ester in volunteers. Antimicrob. Agents Chemother. 25:78-82.
19. Jackson, D., D. L. Cooper, R. Horton, P. F. Langley, D. H. Staniforth, and J. A. Sutton. 1983. Absorption, pharmacokinetic and metabolic studies with Augmentin, p. 83-101. In E. A. P. Croydon and M. F. Michel (ed.), Augmentin: clavulanate-potentiated amoxicillin. Proceedings of the European Symposium. Excerpta Medica, Amsterdam, The Netherlands.
20. Jacobs, M. 1997. Respiratory tract infections: epidemiology and surveillance. J. Chemother. 9(Suppl. 3):10-17.
21. Kafetzis, D. A., C. Carabinos, T. Bairamis, and N. Apostolopoulos. 1993. Diffusion of four oral cephalosporins into the middle car exudate (MEE) of children suffering from acute otitis media (AOM), abstr. 941, p. 291. In Program and abstracts of the 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
22. Kim, H. K., E. I. Cantekin, C. D. Bluestone, and J. S. Reilly. 1983. Pharmacokinetic study of the concentration of amoxicillin in middle ear effusions of children with chronic otitis media with effusion. Ann. Otol. Rhinol. Laryngol. 96:42-44.
23. Klugman, K. 1990. Pneumococcal resistance to antibiotics. Clin. Microbiol. Rev. 3:171-196.
24. Klugman, K., F. Goldstein, S. Kohno, and F. Baquero. 1997. The role of 4th generation cephalosporins in the treatment of infections caused by penicillin-resistant streptococci. Clin. Microbiol. Infect. 3(Suppl. 1):S48-S60.
25. Krause, P. J. 1982. Penetration of amoxicillin, cefaclor, erythromycin-sulfisoxazole and trimethoprim-sulfamethoxazole into the middle ear fluid of patients with chronic serous otitis media. J. Infect. Dis. 145:815-821.
26. Kusmiesz, H., S. Shelton, O. Brown, S. Manning, and J. Nelson. 1990. Loracarbef concentrations in middle ear fluid. Antimicrob. Agents Chemother. 34:2030-2031.
27. Lee, B. L., A. M. Padula, R. C. Kimbrough, S. R. Jones, R. E. Chaisson, J. Mills, and M. A. Sande. 1991. Infectious complications with respiratory pathogens despite ciprofloxacin therapy. N. Engl. J. Med. 325:520-521.
28. Marton, A. 1992. Pneumococcal antibiotic resistance: the problem in Hungary. Clin. Infect. Dis. 15:106-111.
29. Negri, M. C., M. L. Morosini, E. Loza, and F. Baquero. 1994. In vitro selective antibiotic concentrations of β-lactams for penicillin-resistant Streptococcus pneumoniae populations. Antimicrob. Agents Chemother. 38:122-125.
30. Nix, D. E., S. D. Goodwin, C. A. Peloquin, D. L. Rotella, and J. J. Schentag. 1991. Antibiotic tissue penetration and its relevance: impact of tissue penetration on infection. Antimicrob. Agents Chemother. 35:1953-1959.
31. Perez-Trallero, E., J. M. Garcia-Arenzana, J. A. Jimenez, and A. Peris. 1990. Therapeutic failure and selection of resistance to quinolones in a case of pneumococcal pneumonia treated with ciprofloxacin. Eur. J. Clin. Microbiol. Infect. Dis. 9:905-906.
32. Peterson, L. R., J. N. Quick, B. Jensen, S. Homann, S. Johnson, J. Tenquist, C. Shanholtzer, R. A. Petzel, L. Sinn, and D. N. Gerding. 1990. Emergence of ciprofloxacin-resistance in nosocomial methicillin-resistant Staphylococcus aureus (MRSA) isolates during ciprofloxacin plus rifampicin therapy for MRSA colonization. Arch. Intern. Med. 150:2151-2155.
33. Severin, A., E. Severina, and A. Tomasz. 1997. Abnormal physiological properties and altered cell wall composition in Streptococcus pneumoniae grown in the presence of clavulanic acid. Antimicrob. Agents Chemother. 41: 504-510.
34. Sifaoui, F., M. D. Kitzis, and L. Gutmann. 1994. Selection of one step resistant mutants of Streptococcus pneumoniae by different oral β-lactam antibiotics, abstr. C7, p. 72. In Program and abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
35. 34a. Smithkline Beecham Pharmaceuticals. Data on file.
36. Wise, R. 1990. The pharmacokinetics of the oral cephalosporins - a review. J. Antimicrob. Chemother. 26(Suppl. E):13-20.